The findings from human tissue and mouse models suggested that, by regulating the expression of Th17 cytokines and related cytokines, STAT3 and IL-6 may contribute to corticosteroid insensitivity in an asthma model with a mixed Th2/Th17 response and may become a potential target for treatment of T2-low asthma. Here, IL6 is linked to asthma.